Literature DB >> 10691904

Altered in vitro apoptosis of cultured mast cells prepared from an inbred strain of mice, NC/Kuj.

T Hiragun1, E Morita, H Shindo, T Tanaka, Y Kameyoshi, T Okabe, M Kanno, S Yamamoto.   

Abstract

BACKGROUND: An inbred strain of mice, NC, develops dermatitis associated with highly elevated serum IgE and dermal mast cell hyperplasia. OBJECTIVES AND METHODS: To clarify the mechanisms for the dermal mast cell hyperplasia in NC, we prepared bone marrow-derived mast cells (BMMCs) from three strains of mice, NC/Kuj, C57BL/6 and BALB/c, and compare histamine contents, histamine release abilities, adhesive properties and apoptosis of the BMMCs.
RESULTS: Compared with BMMCs obtained from C57BL/6 and BALB/c, NC/Kuj BMMC possessed higher histamine content and higher adhesive ability to plastic plates, although histamine release from BMMCs was found to be similar in the three strains. The most intriguing finding is the lack of apoptosis in the BMMCs from NC/Kuj upon growth factor deprivation as determined by DNA ladder formation and loss of membrane phospholipid asymmetry.
CONCLUSION: The altered in vitro properties of mast cells in NC/Kuj partially account for an increase of dermal mast cells, which might be involved in the development of skin lesions in NC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691904     DOI: 10.1046/j.1365-2222.2000.00726.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  2 in total

1.  Wntless is required for peripheral lung differentiation and pulmonary vascular development.

Authors:  Bridget Cornett; John Snowball; Brian M Varisco; Richard Lang; Jeffrey Whitsett; Debora Sinner
Journal:  Dev Biol       Date:  2013-03-21       Impact factor: 3.582

2.  Establishment of a mast cell line, NCL-2, without Kit mutation, derived from NC mouse bone marrow.

Authors:  Takaaki Hiragun; Yuhki Yanase; Tsutomu Okabe; Makiko Hiragun; Mikio Kawai; Michihiro Hide
Journal:  FEBS Open Bio       Date:  2014-04-02       Impact factor: 2.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.